immunogen.com
Get leads like Immunogen — and thousands more
Build targeted lists by tech stack, and more
Immunogen: The $127M Oncology Powerhouse
A deep dive into the biotech firm's clinical-stage dominance and growth trajectory
In the high-stakes arena of oncology, Immunogen is quietly executing a precision strike on cancer cells. With a $127M revenue engine and 461 employees, they're not just another biotech startup—they're a clinical-stage powerhouse redefining antibody-drug conjugates.
"This isn't a website-first biotech—this is a clinical-stage machine where the website is merely a corporate front. The real action happens in labs and clinical trials, not on SEO-optimized landing pages."
The Clinical Focus
Immunogen (IMGN) operates in the ultra-competitive ADC (Antibody-Drug Conjugate) space. Their flagship platform targets cancers with precision, delivering cytotoxic payloads directly to tumor cells while sparing healthy tissue. With Mark Enyedy at the helm as President and CEO, they've built a specialized team of 461 focused on one thing: getting drugs through clinical trials and to patients.
The Revenue Story
The $127.7M revenue figure is telling. Unlike many pre-revenue biotechs burning cash, Immunogen has monetized its platform through partnerships and milestone payments. The $55M in funding represents strategic capital for pipeline expansion, not survival money. This is a company in the growth phase of the clinical development cycle.
The tech stack reveals their priorities: jQuery, Tailwind CSS, Bootstrap, and Cloudflare. This isn't a consumer-facing digital health app—it's a corporate site built for investor relations and scientific credibility. The absence of sophisticated analytics tools or conversion funnels tells the real story: their website is a communication channel, not a customer acquisition engine.
- 461 employees focused on clinical development, not digital marketing
- $127.7M revenue from milestone payments and partnerships
- Specialized leadership team with deep oncology expertise
- Clinical-stage focus over consumer-facing digital products
The Biotech Paradox
Immunogen proves that in biotech, clinical execution matters more than digital presence. Their $127M revenue validates this approach.
What tech stack does Immunogen use?
How much traffic does Immunogen get?
Traffic & Engagement
How is Immunogen's SEO?
Meta Tags
ImmunoGen is now part of AbbVie | AbbVie
ImmunoGen is now part of AbbVie
H1 Tags
What is Immunogen's revenue?
Who works at Immunogen?
Loading leads...
What do customers think of Immunogen?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Immunogen
What is Immunogen's Revenue?
How fast is Immunogen growing?
What technologies does Immunogen use?
Who are Immunogen's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Immunogen?
Contact Information
Export immunogen.com Data
Download the complete tech stack, analytics, leads, and company data for immunogen.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About immunogen.com
Company Overview
immunogen.com Social Media
Contact immunogen.com
Phone Numbers
Technology Stack
immunogen.com uses 12 technologies across their website including YouTube Embed, Google Fonts, Cloudflare, and more.
Video
YouTube Embed
Fonts
Google Fonts
Cloud & Hosting
Cloudflare
Privacy & Consent
OneTrust
Advertising
DoubleClick Floodlight
Analytics & Marketing
Google Tag Manager
Traffic & Audience
immunogen.com receives approximately 0 monthly visitors. The website has a bounce rate of 0% with visitors viewing an average of 0.0 pages per visit. Users spend an average of 0:00 on the site.
Frequently Asked Questions
What is immunogen.com?
What technologies does immunogen.com use?
How do I contact immunogen.com?
What are immunogen.com's social media accounts?
Is immunogen.com hiring?
How popular is immunogen.com?
Related Searches
This page provides publicly available information about immunogen.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit immunogen.com directly at https://immunogen.com.